Humans

Prescription drugs tied to digestive cancer risk in older adults

In a scan of 442 oral prescription drugs, 218 were associated with digestive cancer risk and 28 showed an inverse association.

Cancer Epidemiology, Biomarkers & Prevention

In older adults from the SEER-Medicare database, researchers evaluated potential links between oral prescription medications and digestive cancer risk. Older adults increasingly use prescription drugs, but traditional clinical trials are not designed to assess long-term outcomes such as digestive cancers, which directly participate in drug absorption and metabolism. To systematically detect these signals, the authors conducted a multi-stage case-control drug-wide association study across 442 oral prescription medications. Follow-up analyses addressed confounding by adjusting for comorbidities and incorporating active comparators alongside propensity scores. In the initial scan, 218 drugs were associated with digestive cancer, and 28 were inversely associated. The study confirmed several previously reported associations while revealing novel drug-cancer relationships.

Why it matters

Older adults frequently manage multiple chronic conditions with long-term medications. Identifying how widespread prescription drug use associates with digestive cancer risk can uncover potential safety signals and protective effects in aging populations.

Caveats

The findings are observational and hypothesis-generating from a case-control design. The authors note that the results require targeted confirmation in prospective studies and further analysis into the specific cancer types driving the observed associations.

The paper

Uncovering hypothesis-generating associations between prescription drugs and digestive cancer risk: a case-control drug-wide association study (DWAS)

Cornell University · Memorial Sloan Kettering Cancer Center

Cancer Epidemiology, Biomarkers & Prevention · 28 Sep 2026

doi.org/10.1158/1055-9965.epi-26-0907PubMed 42808885